Medtronic: Myocardial Infarction trials
The registry lists 14 Myocardial Infarction studies with Medtronic as lead sponsor. 0 are open to participants now and 5 have results posted.
No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Resolute Integrity US Extended Length Sub-Study(RI US XL)CompletedNCT01913600Not applicableResults posted
- An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent SystemCompletedNCT01638507Not applicableResults posted
- RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary StentCompletedNCT00927940Not applicableResults posted
- The Medtronic RESOLUTE US Clinical TrialCompletedNCT00726453Not applicableResults posted
- IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient SettingCompletedNCT00303979Results posted
- RESOLUTE ONYX China Single Arm StudyCompletedNCT03471845Not applicable
- RESOLUTE ONYX China RCT StudyCompletedNCT03466151Not applicable
- China Resolute Integrity 34/38 mm StudyCompletedNCT03118531Not applicable
- MAGNetic QRS-Fragmentation in Patients With Myocardial InfarcTion and Moderately RedUceD Ejection FractionTerminatedNCT01972126
- RESOLUTE China RCTCompletedNCT01334268Not applicable
- RESOLUTE China Registry:CompletedNCT01243749
- RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in AsiaCompletedNCT01132456Not applicable
- MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI PatientsCompletedNCT00305240Not applicable
- MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI PatientsCompletedNCT00305214Not applicable